BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5611161)

  • 21. [Chronology of abnormal mitosis of adenocarcinoma of the uterine cervix "in vitro". Influence on determinations of the proliferative activity].
    Grigolo B; Maistri S
    Attual Ostet Ginecol; 1967; 12(2):133-7. PubMed ID: 5602897
    [No Abstract]   [Full Text] [Related]  

  • 22. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of survival and side effects in two periods with a different approach to radical hysterectomy as treatment of cervical cancer stages Ib and IIa.
    Knudsen HJ; Rasmussen KL; Ledertoug S; Mamsen A; Nyland MH; Jakobsen A
    Zentralbl Gynakol; 1995; 117(9):476-80. PubMed ID: 7483882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal glandular cells in a cervical smear.
    Juric D; Ovanin-Rakić A; Audy-Jurković S; Kani D; Ilić-Forko J; Buković D
    Cytopathology; 2006 Oct; 17(5):299-300. PubMed ID: 16961660
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ovarian metastasis in uterine cervical cancer: analysis of 17 cases].
    Ma S; Sun J
    Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):305-7. PubMed ID: 9206188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
    Frigerio L; Mariani A; Gandini L; Origoni M; Galli L; Rabaiotti E; Aletti G; Ferrari A
    Int Surg; 1998; 83(3):265-70. PubMed ID: 9870789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
    Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
    Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cancer of the L-shaped kidney].
    Shipilov VI; Bukharkin BV; Gotsadze DT
    Urol Nefrol (Mosk); 1983; (1):59-60. PubMed ID: 6829095
    [No Abstract]   [Full Text] [Related]  

  • 29. [On very late recurrence of cervical carcinoma].
    Bernardi GC; Gilardi G
    Minerva Ginecol; 1968 Oct; 20(19):1560-1. PubMed ID: 5740784
    [No Abstract]   [Full Text] [Related]  

  • 30. Adenocarcinoma of the uterine cervix: a study of 37 cases.
    Piura B; Dgani R; Yanai-Inbar I; Cohen Y; Glezerman M
    J Surg Oncol; 1996 Apr; 61(4):249-55. PubMed ID: 8627993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Invasive cancer of the uterine cervix].
    Elbaze R
    Soins; 1980 Jan; 25(1):23-9. PubMed ID: 6899411
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix.
    Kasamatsu T; Onda T; Sasajima Y; Kato T; Ikeda S; Ishikawa M; Tsuda H
    Gynecol Oncol; 2009 Dec; 115(3):488-92. PubMed ID: 19767067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modern treatment of early-stage cervical cancer].
    Ivanov S; Tiufekchieva E
    Akush Ginekol (Sofiia); 2006; 45(7):3-5. PubMed ID: 17489161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
    Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis.
    Tsai CC; Liu YS; Huang EY; Huang SC; Chang HW; Tseng CW; ChangChien CC
    Gynecol Oncol; 2006 Mar; 100(3):591-5. PubMed ID: 16290001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of high risk HPV lymph node positivity in the surgical staging of cancer of the uterine cervix.
    Sápy T; Hernádi Z; Lukácskó L; Borsos A
    Acta Chir Hung; 1997; 36(1-4):313-5. PubMed ID: 9408386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed papillary transitional cell carcinoma and adenocarcinoma of the uterine cervix: a clinicopathologic study of three cases.
    Robinson CE; Sarode VR; Albores-Saavedra J
    Int J Gynecol Pathol; 2003 Jul; 22(3):220-5. PubMed ID: 12819386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Villograndular adenocarcinoma of uterine cervix: a case report].
    Reale D; Vitullo G; Di Virgilio M; Trubiani O; Pizzicannella G
    Pathologica; 2001 Apr; 93(2):128-31. PubMed ID: 11428290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.